The alignment of the immunoblots in [Figure 1A](#pgen-1004778-g001){ref-type="fig"} is incorrect. The authors have provided a corrected version here.

![Functional characteristics of the nine *CFTR^BD^* variants.\
Panel **a**. Wild-type (WT) and variant CFTR proteins were expressed in HEK 293T cells and immunoblotted with anti-CFTR and anti-Aldolase antibodies. Replicate lanes are in small font. Band B, expected size of immature ER core-glycosylated CFTR; band C, mature complex-glycosylated CFTR. Panel **b**. Whole-cell Cl^−^ currents were measured in WT and variant CFTR-expressing HEK 293T cells, as described in Methods. Panel **c**. Whole-cell currents of WT-CFTR were measured in HEK 293T cells co-expressed with WNK1 and SPAK using patch pipette contained a low concentration of Cl^−^ (10 mM). A representative trace of reversal potential measurement is shown in the left panel. The permeability ratio P~HCO3~/P~Cl~ was calculated according to the Goldman-Hodgkin-Katz equation. I--V relationships at the indicated points are presented in the accompanying graph. The conductance ratio G~HCO3~/G~Cl~ was calculated by measuring each outward current (i.e., slope between E~rev~ and E~rev+25~ mV). RMP, resting membrane potential. Panel **d**. Whole-cell currents of R170H-CFTR were measured in HEK 293T cells using the same protocol shown in panel **c**. Panel **e**. A summary of the P~HCO3~/P~Cl~ values obtained from WT-CFTR in the standard state (left) compared to WT-CFTR and the nine *CFTR^BD^* variants with WNK1 + SPAK activation (right, underlined). Panel **f**. A summary of the G~HCO3~/G~Cl~ values in the standard state (left) with WNK1 + SPAK activation (right). Values throughout are means ± SEM. \* p\<0.05, \*\*p\<0.01: difference from WT in cells co-expressed with WNK1 and SPAK.](pgen.1004778.g001){#pgen-1004778-g001}
